logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
For ProvidersRequest DemoJoin Research Panel
For BusinessHCP ChannelCommercial O/SEngageMarketplaceOneHubInsight
Tools & MorePrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutInsightsCareersContactSecurity
Legit Script Certified
Get the latest insights in your inbox
Follow us
Legit Script Certified
  • Terms and Conditions
  • Privacy Policy
  • © 2025 PrescriberPoint. All Rights Reserved.

    • Encube Ethicals Private Limited drugs

    FiltersReset Filters
    28 results

    • adapalene gel usp, 0.3% - adapalene gel usp, 0.3% gel

      (Adapalene Gel Usp, 0.3%)
      Encube Ethicals Private Limited

    • azelaic acid gel

      (Azelaic Acid)
      Encube Ethicals Private Limited
      Usage: Azelaic Acid Gel, 15% is indicated for the topical treatment of inflammatory papules and pustules associated with mild to moderate rosacea. Efficacy for treating rosacea-related erythema without papules and pustules has not been established.

    • ciclopirox

      (ciclopirox)
      Encube Ethicals Private Limited
      Usage: Ciclopirox topical solution, 8% (nail lacquer), is indicated for treating mild to moderate onychomycosis of fingernails and toenails in immunocompetent patients. It should be part of a comprehensive management program, including nail removal by a qualified healthcare professional, and is not recommended for use with systemic antifungal agents.

    • clindamycin phosphate

      (Clindamycin Phosphate)
      Encube Ethicals Private Limited
      Usage: Clindamycin phosphate topical lotion is indicated for the treatment of acne vulgaris. Due to risks of diarrhea and pseudomembranous colitis, physicians should evaluate the appropriateness of other treatments.

    • clindamycin phosphate - clindamycin phosphate gel usp, 1% gel

      (Clindamycin Phosphate Gel Usp, 1%)
      Encube Ethicals Private Limited

    • clobetasol propionate - clobetasol propionate ointment usp, 0.05% ointment

      (Clobetasol Propionate Ointment Usp, 0.05%)
      Encube Ethicals Private Limited

    • clobetasol propionate - clobetasol propionate solution

      (Clobetasol Propionate)
      Encube Ethicals Private Limited

    • desonide ointment, 0.05%

      (Desonide Ointment, 0.05%)
      Encube Ethicals Private Limited

    • estradiol gel

      (Estradiol)
      Encube Ethicals Private Limited
      Usage: The drug is indicated for the treatment of specific medical conditions, aiding in symptom relief and management. Always consult a healthcare provider for appropriate use tailored to individual health needs.

    • fluorouracil

      (Fluorouracil)
      Encube Ethicals Private Limited
      Usage: Fluorouracil is indicated for the topical treatment of multiple actinic or solar keratoses and, in 5% strength, superficial basal cell carcinomas when conventional methods are impractical. Its safety and efficacy for other conditions are not established, and diagnosis must be confirmed prior to treatment.